Advanced

Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome

Balkau, Beverley; Charles, Marie-Aline; Drivsholm, Thomas; Borch-Johnsen, Knut; Wareham, Nick; Yudkin, John S; Morris, Richard; Zavaroni, Ivana; van Dam, Rob and Feskins, Edith, et al. (2002) In Diabetes & Metabolism1996-01-01+01:00 28(5). p.364-376
Abstract
BACKGROUND: To describe the frequency, in some European populations, of the World Health Organisation (WHO) defined metabolic syndrome and to compare the frequency of this syndrome with an alternative definition for non-diabetic subjects, called the insulin resistance syndrome proposed by the European Group for the Study of Insulin Resistance (EGIR). METHODS: Investigators of eight European studies contributed, according to a written protocol, the frequencies of abnormalities of these two syndromes, by sex and age class, as well as the overall frequencies of the syndromes and the average number of abnormalities: 8200 men and 9363 women were included. RESULTS: The frequency of both syndromes increased with age and was almost always higher... (More)
BACKGROUND: To describe the frequency, in some European populations, of the World Health Organisation (WHO) defined metabolic syndrome and to compare the frequency of this syndrome with an alternative definition for non-diabetic subjects, called the insulin resistance syndrome proposed by the European Group for the Study of Insulin Resistance (EGIR). METHODS: Investigators of eight European studies contributed, according to a written protocol, the frequencies of abnormalities of these two syndromes, by sex and age class, as well as the overall frequencies of the syndromes and the average number of abnormalities: 8200 men and 9363 women were included. RESULTS: The frequency of both syndromes increased with age and was almost always higher in men than women for a given age. In non-diabetic subjects the frequency of the WHO syndrome varied between 7% and 36% for men 40 to 55 years; for women of the same age, between 5% and 22%. The EGIR syndrome was less frequent than the WHO syndrome (1% to 22% in men, 1% to 14% in women 40-55 years), and in men this was mainly due to the differing definitions of central obesity, as the WHO definition included overall obesity, BMI > or = 30 kg/m(2). CONCLUSIONS: There is great variability in the frequency of the syndrome between different populations, due to the differing frequencies of the abnormalities and no doubt to the differing methodologies of measurement. Prospective studies and advances in the knowledge of physio-pathological mechanisms are required to determine the most appropriate and practical definition of the syndrome. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Diabetes & Metabolism1996-01-01+01:00
volume
28
issue
5
pages
364 - 376
publisher
Masson Editeur
external identifiers
  • pmid:12461473
  • scopus:0036861687
ISSN
1878-1780
language
English
LU publication?
yes
id
4d096681-1a82-470a-8b8a-702bc4e132e5 (old id 1123781)
alternative location
http://www.masson.fr/masson/portal/bookmark;jsessionid=5835E1B5FB8A1A9A0DA4F8EA61F69C4B.lbmastin3?Global=1&Page=18&MenuIdSelected=106&MenuItemSelected=0&MenuSupportSelected=&CodeRevue4=DM&CodeProduct4=535&Path=REVUE/DM/2002/28/5/ARTICLE1110832753.xml&Locations=&Pos=3
date added to LUP
2008-05-19 08:24:31
date last changed
2017-12-10 04:26:28
@article{4d096681-1a82-470a-8b8a-702bc4e132e5,
  abstract     = {BACKGROUND: To describe the frequency, in some European populations, of the World Health Organisation (WHO) defined metabolic syndrome and to compare the frequency of this syndrome with an alternative definition for non-diabetic subjects, called the insulin resistance syndrome proposed by the European Group for the Study of Insulin Resistance (EGIR). METHODS: Investigators of eight European studies contributed, according to a written protocol, the frequencies of abnormalities of these two syndromes, by sex and age class, as well as the overall frequencies of the syndromes and the average number of abnormalities: 8200 men and 9363 women were included. RESULTS: The frequency of both syndromes increased with age and was almost always higher in men than women for a given age. In non-diabetic subjects the frequency of the WHO syndrome varied between 7% and 36% for men 40 to 55 years; for women of the same age, between 5% and 22%. The EGIR syndrome was less frequent than the WHO syndrome (1% to 22% in men, 1% to 14% in women 40-55 years), and in men this was mainly due to the differing definitions of central obesity, as the WHO definition included overall obesity, BMI > or = 30 kg/m(2). CONCLUSIONS: There is great variability in the frequency of the syndrome between different populations, due to the differing frequencies of the abnormalities and no doubt to the differing methodologies of measurement. Prospective studies and advances in the knowledge of physio-pathological mechanisms are required to determine the most appropriate and practical definition of the syndrome.},
  author       = {Balkau, Beverley and Charles, Marie-Aline and Drivsholm, Thomas and Borch-Johnsen, Knut and Wareham, Nick and Yudkin, John S and Morris, Richard and Zavaroni, Ivana and van Dam, Rob and Feskins, Edith and Gabriel, Rafael and Diet, Malmo and Nilsson, Peter and Hedblad, Bo},
  issn         = {1878-1780},
  language     = {eng},
  number       = {5},
  pages        = {364--376},
  publisher    = {Masson Editeur},
  series       = {Diabetes & Metabolism1996-01-01+01:00},
  title        = {Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome},
  volume       = {28},
  year         = {2002},
}